Charles River Laboratories Other Long-Term Assets 2010-2024 | CRL

Charles River Laboratories other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Charles River Laboratories other long-term assets for the quarter ending September 30, 2024 were $0.307B, a 98.23% increase year-over-year.
  • Charles River Laboratories other long-term assets for 2023 were $0.309B, a 108.65% increase from 2022.
  • Charles River Laboratories other long-term assets for 2022 were $0.148B, a 2.15% decline from 2021.
  • Charles River Laboratories other long-term assets for 2021 were $0.152B, a 85.89% decline from 2020.
Charles River Laboratories Annual Other Long-Term Assets
(Millions of US $)
2023 $309
2022 $148
2021 $152
2020 $1,074
2019 $826
2018 $682
2017 $426
2016 $409
2015 $285
2014 $234
2013 $62
2012 $49
2011 $58
2010 $62
2009 $53
Charles River Laboratories Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $307
2024-06-30 $301
2024-03-31 $303
2023-12-31 $309
2023-09-30 $155
2023-06-30 $155
2023-03-31 $154
2022-12-31 $148
2022-09-30 $1,340
2022-06-30 $1,401
2022-03-31 $1,305
2021-12-31 $152
2021-09-30 $1,354
2021-06-30 $1,322
2021-03-31 $1,062
2020-12-31 $1,074
2020-09-30 $980
2020-06-30 $957
2020-03-31 $950
2019-12-31 $826
2019-09-30 $814
2019-06-30 $827
2019-03-31 $683
2018-12-31 $682
2018-09-30 $700
2018-06-30 $703
2018-03-31 $441
2017-12-31 $426
2017-09-30 $414
2017-06-30 $400
2017-03-31 $393
2016-12-31 $409
2016-09-30 $405
2016-06-30 $418
2016-03-31 $279
2015-12-31 $285
2015-09-30 $66
2015-06-30 $63
2015-03-31 $71
2014-12-31 $234
2014-09-30 $84
2014-06-30 $82
2014-03-31 $64
2013-12-31 $62
2013-09-30 $57
2013-06-30 $54
2013-03-31 $49
2012-12-31 $49
2012-09-30 $41
2012-06-30 $41
2012-03-31 $47
2011-12-31 $58
2011-09-30 $57
2011-06-30 $56
2011-03-31 $65
2010-12-31 $62
2010-09-30 $65
2010-06-30 $53
2010-03-31 $54
2009-12-31 $53
2009-09-30 $53
2009-06-30 $61
2009-03-31 $51
Sector Industry Market Cap Revenue
Medical Medical Services $11.014B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.015B 12.16
Cencora (COR) United States $48.948B 18.05
DiDi Global (DIDIY) China $23.622B 0.00
ICON (ICLR) Ireland $17.731B 15.79
Natera (NTRA) United States $16.587B 0.00
Viatris (VTRS) United States $15.469B 4.76
Avantor (AVTR) United States $15.375B 23.05
Revvity (RVTY) United States $14.905B 25.89
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.590B 0.00
Solventum (SOLV) United States $12.509B 0.00
Medpace Holdings (MEDP) United States $11.276B 31.77
Doximity (DOCS) United States $10.815B 64.01
HealthEquity (HQY) United States $8.629B 46.83
Sonic Healthcare (SKHHY) Australia $8.542B 0.00
Bausch + Lomb (BLCO) Canada $7.043B 32.79
Life Times (LTH) United States $5.170B 34.22
Sotera Health (SHC) United States $4.557B 24.38
Organon (OGN) United States $4.131B 4.17
Surgery Partners (SGRY) United States $3.859B 42.76
BrightSpring Health Services (BTSG) United States $3.408B 72.48
PACS (PACS) United States $3.251B 0.00
Alignment Healthcare (ALHC) United States $2.620B 0.00
Concentras Parent (CON) United States $2.500B 0.00
Ardent Health Partners (ARDT) United States $2.337B 0.00
Premier (PINC) United States $2.292B 11.44
GeneDx Holdings (WGS) United States $2.137B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.589B 0.00
Progyny (PGNY) United States $1.499B 26.37
Pediatrix Medical (MD) United States $1.353B 13.24
Establishment Labs Holdings (ESTA) $1.292B 0.00
CareDx (CDNA) United States $1.268B 0.00
AMN Healthcare Services Inc (AMN) United States $1.104B 7.49
Embecta (EMBC) United States $0.897B 5.98
InnovAge Holding (INNV) United States $0.813B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.757B 0.00
SBC Medicals (SBC) United States $0.706B 0.00
Auna S.A (AUNA) Luxembourg $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.469B 0.00
DocGo (DCGO) United States $0.409B 15.38
Enhabit (EHAB) United States $0.397B 34.30
COMPASS Pathways (CMPS) United Kingdom $0.373B 0.00
LifeMD (LFMD) United States $0.252B 0.00
Sera Prognostics (SERA) United States $0.225B 0.00
ModivCare (MODV) United States $0.221B 12.05
Beauty Health (SKIN) United States $0.202B 0.00
Biodesix (BDSX) United States $0.199B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.129B 0.00
So-Young (SY) China $0.089B 21.63
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.055B 0.00
OncoCyte (OCX) United States $0.048B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.036B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00